Nova Capital is a venture capital and private equity-style capital provider offering equity financing to privately held and publicly traded companies. Typical investments range from $25 million to $250 million for expansion, industry consolidation, internal growth and strategic acquisitions. It is most relevant for later-stage financings, while also having participated in seed and Series A rounds in health technology, biotechnology, pharmaceuticals and AI. The firm’s investment geography spans the United States, Europe, the Middle East and Asia, with specific activity in Israel and Poland.